This report was recently updated on April 16 2024 with the latest and most recent
market numbers
Global Automated Biopsy Guns & Needles Market Size, Trends & Analysis - Forecasts to 2026 By Product Type (Automatic, and Semi-Automatic), By Gauge Size (14 Gauge Biopsy Needle, 16 Gauge Biopsy Needle, and 18 Gauge Biopsy Needle), By Usage (Disposable and Reusable), By Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy, Kidney Biopsy,Colorectal Biopsy, Bone Biopsy, and Other Application) Competitive Landscape, Company Market Share Analysis, and Competitor Analysis
Automatic biopsy guns and needles are devices that use a disposable needle to extract high-quality and specific histological specimens from the patient. It is a methodology to extract cells and tissues from the patient’s body by embedding a needle in the tumor site. The extricated tissue is then utilized for lab testing in order to discover any irregularity and abnormalities. The major application of biopsy is the detection or presence of mass or a lump, infection, and any type of inflammation. A biopsy is most commonly used for cancer tumor detection across the globe. The market commonly has fine-needle aspiration and core needle biopsy which is regularly used for cancer diagnostics. Tissues or samples such as bones, blood samples, muscles, and,organ samples of lung and liver are mainly extracted. However, the market for needle biopsy is moving towards using automatic and semi-automatic biopsy guns. Automatic biopsy needles or guns are spring-loaded for quick and accurate penetration and extraction of tissue samples. The automatic type allows the user to get a précised controlover the extraction and also renders high-quality sampling capability the users need while handling and working with hard, calcified,and fibrous tumors/ lesions. Hence, this single-hand operating device is taking over the market and will grow with a higher CAGR rate from 2021-2026. The major end-users for automatic biopsy needles are cancer hospitals, clinics, and research centers that perform cancer profiling for pre and post-diagnostic purposes.
Rising cancer prevalence across the world and increasing preference for pre-cancer diagnosis are supporting the rising demand for biopsy guns. Moreover, factors such as the increasing supportive initiatives by the government and major healthcare organizations for cancer awareness and early diagnosis, and the rising demand for minimally invasive procedures will support the market demand.
Based on the type of biopsy needle or gun, the market is split into automatic and semi-automatic segments. The automatic needle biopsy product will be the largest shareholder in the market from 2021 to 2026. This is mainly due to the added advantage of the automation which gives précised controlover the extraction and renders high-quality sampling capability the users need while handling and working with hard, calcified,and fibrous tumors/ lesions. Increasing product launches related to automatic biopsy needles will boost the demand in the market during the forecast period.
Based on gauge size, the market is segregated into 14 gauge biopsy needles, 16 gauge biopsy needles, and 18 gauge biopsy needles. Different gauge sizes are used for a different types of biopsies. For instance, a gauge size of 14 is best for breast biopsy which is superficial while gauge size 16 is the best fit for liver and kidney biopsy as it comes under the core biopsy site. However, owing to rising cases of liver and kidney biopsy, the market for 16 gauge biopsy needles is the largest from 2021 to 2026.
Based on usage type, the market is segmented into disposable, and reusable needles. The disposable automated biopsy guns will be the dominant segment in the market from the forecast period of 2021 to 2026. In order to reduce the chances and minimize the chances of cross-contamination cases during the biopsies conducted on more than one patient, many doctors and patients are demanding and preferring for disposable needles as compared to reusable needles. Also increasing organic strategies conducted by the top players in the market will also support the growth of the segment during the forecast period.
Based on application, the market is split into breast biopsy, lung biopsy, kidney biopsy, prostate biopsy, colorectal biopsy, bone biopsy, and other applications. The most common type of biopsy conducted across all the markets is the kidney biopsy and hence it will be the largest and dominant segment from 2021 to 2026. As per the WHO statistics, as of 2019, around 73,750 people (28,230 women& 45,520 men) in the US have been diagnosed with kidney cancer. Moreover, Kidney cancer is the most common type of cancer for both men and women ranking 6th in the list.
As per the geographical analysis, the market can be classified into North America (the United States, Canada, and Mexico), Asia Pacific (India, China, Japan, Malaysia, Singapore, and Rest of Asia Pacific), Europe (Germany, United Kingdom, Italy, France, Spain, Netherlands, and Rest of Europe), Middle East & Africa (Saudi Arabia, United Arab Emirates, and Rest of the Middle East & Africa) and Central South America (Brazil, Argentina, and Rest of Central and South America). Based on the market value or revenue generation, North America (the US, Canada, and Mexico) is anticipated to be the leading regional contributor to the automated biopsy guns and needles market. The presence of top market players in these countries will continue to account for a substantial share in the market throughout the forecast period. High market penetration rates of technologically advanced biopsy needles and rapidly growing demand for disposable devices are expected to help the North American market be dominant throughout the forecast period. On the other hand, the Asian region will grow the fastest, owing to the increasing prevalence of cancer and rising medical tourism for cancer treatment.
Argon Medical Devices, Biopsybell, Histo, STERYLAB, Vigeo, Merit Medical System, Adria Medical, UROMED Kurt Drews KG, Mermaid Medical, Medi-Tech Devices, weLLgo Medical Products GmbH, Zamar Care, Seedos Ltd, Delta Surgical, Advin Health Care, Blue Neem Medical Devices Pvt Ltd, Möller Medical GmbH, Geotek Medical, Varaylaborix, and Advanced Life-sciences PVT. LTD.among others are the key players in the automated biopsy guns & needles market.
Please note: This is not an exhaustive list of companies profiled in the report.
We value your investment and offer free customization with every report to fulfil your exact research needs.
The Global Automated Biopsy Guns & Needles Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Automated Biopsy Guns & Needles Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
